Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Blue Freeform 8 mm, Film coated tablet with imprint "SB;4894". It contains Ropinirole hydrochloride 5 mg; of Ropinirole hydrochloride[ropinirole];. This belongs to the Nonergot dopamine agonist pharmacologic class. It is manufactured by GlaxoSmithKline LLC. For details please contact your physician.
Basic Information
- Imprint
- SB;4894
- Color
- Blue
- Shape
- Freeform
- Size
- 8 mm
Drug Information
- Strength
- Ropinirole hydrochloride 5 mg;
- Dosage Form
- Film coated tablet
- RxCUI
- 152955
Pharmaceutical Classification
- Pharmacologic Class
- Nonergot dopamine agonist
Related Medications
Other drugs in the same class: Nonergot Dopamine Agonist
- Mirapexpramipexole dihydrochloride 0.125 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 0.375 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 0.75 mg;WHITE • ROUND
- Mirapexpramipexole dihydrochloride 1.5 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 1.5 mg;WHITE • OVAL
- Mirapexpramipexole dihydrochloride 1 mg;WHITE • ROUND
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 2.25 mg;WHITE • OVAL
- Mirapexpramipexole dihydrochloride .250 mg;WHITE • OVAL
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 3 mg;WHITE • OVAL
- MirapexPRAMIPEXOLE DIHYDROCHLORIDE 4.5 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Ropinirole hydrochloride[ropinirole];
- Inactive Ingredients
- Croscarmellose sodium;lactose monohydrate;magnesium stearate;microcrystalline cellulose;hypromellose 2910 (3 mpa.s);hypromellose 2910 (6 mpa.s);polyethylene glycol 400;titanium dioxide;indigotindisulfonate sodium;fd&c blue no. 2;aluminum oxide;
Additional Information
- Manufacturer
- GlaxoSmithKline LLC
- Status (Rx/OTC)
- Not found
- Brand Names
- Requip
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.